Cite

HARVARD Citation

    Weiss, J. et al. (2016). Capecitabine and lapatinib for the first‐line treatment of metastatic/recurrent head and neck squamous cell carcinoma. Cancer. 122 (15), pp. 2350-2355. [Online]. 
  
Back to record